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MINI REVIEW
Periodontitis, pathogenesis and progression: miRNA-mediated cellular
responses to Porphyromonas gingivalis
Ingar Olsena, Sim K. Singhraob and Harald Osmundsena
aDepartment of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; bDementia & Neurodegeneration Research Group,
Faculty of Clinical and Biomedical Sciences, School of Dentistry, University of Central Lancashire, Preston, UK
ABSTRACT
Porphyromonas gingivalis is considered a keystone pathogen in periodontitis, a disease
typically driven by dysbiosis of oral inflammophilic polymicrobial pathobionts. To combat
infectious agents, the natural defense response of the host is to switch on inflammatory
signaling cascades, whereby microRNA (miRNA) species serve as alternative genetic inhibitory
transcriptional endpoints. miRNA profiles from diseased sites differ from those detected in
disease-free tissues. miRNA profiles could therefore be harnessed as potential diagnostic/
prognostic tools. The regulatory role of some miRNA species (miRNA-128, miRNA-146, miRNA-
203, and miRNA-584) in the innate immune system suggests these molecular signatures also
have potential in therapy. P. gingivalis–associated miRNAs are likely to influence the innate
immune response, whereas its lipopolysaccharide may affect the nature of host miRNAs and
their mRNA targets. This mini review discusses miRNA-dependent transcriptional and regula-
tory phenomena ensuing immune signaling cascade switch-on with development and pro-
gression of periodontitis initiated by P. gingivalis exposure.
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MicroRNAs (miRNAs) constitute a family of small
(~22 bases long), single-stranded, non-coding RNA
molecules that selectively regulate translation of spe-
cific mRNAs. Numerous reports have identified the
pathways of miRNA biogenesis [1], and a full
description of this process is not within the scope of
this mini review. It is important to remember that
miRNAs are integral inhibitory signaling molecules
generated from a primary transcript, which then
causes an inhibitory function on a specific mRNA
species. Briefly, their biogenesis involves primary
miRNA (pri-miRNA) being transcribed by RNA
polymerases II or III from either introns or intergenic
regions [1]. Pri-miRNA is converted into precursor
miRNA (pre-miRNA) by the microprocessor com-
plex (MPC) unit, which consists of class 2 ribonu-
clease III enzyme (Drosha) and MPC subunit DGCR8
(Prasha). Pre-miRNAs are exported from the nucleus
to the cytoplasm by exportin-5 where they undergo
further cleavage by endoribonuclease (Dicer) into the
miRNA/*miRNA duplex. In any one cell, usually one
strand of the duplex remains as the mature miRNA
and is incorporated into the miRNA-induced silen-
cing complex (miRNAISC) with GW 182 proteins
(recruited to the miRNA repressor complex in con-
cert with Argonaute proteins) and Argonaute protein.
The CCR4-NOT complex (a nine-subunit protein
complex found widely in eukaryotes) recruited by
GW182 causes translation inhibition of the mRNA
and/or leads to de-adenylation of its poly (A) tail and
subsequent degradation of the mRNA.
miRNA species appear to regulate diverse cellular
functions (proliferation, metabolism, to tumorigen-
esis and adaptive immune pathways) in concert with
their specific mRNAs. miRNAs function by exerting
their sequence-specific binding to specific mRNAs,
located primarily in the 3´ untranslated region
(UTR). A key point here is that several miRNA spe-
cies are capable of selectively targeting a single
mRNA, whereas one miRNA may be targeted by
several mRNAs. In this way, miRNAs can regulate
the rate of mRNA translation. Therefore, changes in
cellular levels of miRNAs are invariably associated
with changes in the levels of target mRNA genes.
This is likely to have a significant effect on down-
stream protein translation [1] because about 60% of
all protein-coding genes are likely to have been
miRNA targets [2].
miRNAs can affect both the innate and the adap-
tive immune systems [1]. Indeed, in diseased tissues
(cardiovascular and Alzheimer’s diseases), substantial
changes in the cellular levels of miRNAs have been
described [3]. The ensuing miRNA profiles are poten-
tially useful as bio/prognostic markers for diseased
tissues [4], including periodontitis-affected periodon-
tium [5]. Recently, it was described how
Porphyromonas gingivalis, a keystone pathogen in
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periodontal disease, subverts both the innate and the
adaptive immune responses, thereby facilitating its
own survival and that of its radicalized co-species in
the periodontal pocket [6–8]. The extent to which
miRNAs are involved in this phenomenon remains
under investigation, but differentially expressed genes
encoding proteins associated with the innate immune
responses appear to be associated with periodontitis-
affected tissues [9,10].
The classical approach in studying miRNAs
involves building their profiles from diseased and
normal tissues. This facilitates the isolation and sub-
sequent identification of differentially expressed
miRNAs using appropriate software packages. The
association of biological functions to differentially
expressed miRNAs entails target mapping by using
target analysis software, for example ShotStat 2.0
Target Analysis Software or Ingenuity® Pathways
Analysis (IPA®) Software. Although an exploratory
exercise, the concurrent profiling and identification
of differentially expressed mRNAs is likely to facil-
itate greater significance in associations between
miRNAs and mRNA targets. This also applies to
likely functions of miRNAs in immune and stress
responses in periodontal disease, as described by
Kebschull and Papapanou [1] and Irwandi and
Vacharaksa [11].
The aim of this mini review is twofold: first, to
assess current knowledge as regards altered miRNA
profiles found in P. gingivalis–mediated inflamed per-
iodontium; and second, to determine possible func-
tions of differentially expressed miRNAs in direct
response to immune reactions that paradoxically
facilitate bacterial survival and consequently promote
pathogenesis/progression of periodontal disease.
Key features of the innate immune response to P.
gingivalis lipopolysaccharide (LPS, endotoxin)
involves initiation of various signaling cascades
within immune cells, for example neutrophils. Since
neutrophils play key roles in maintaining periodontal
health, most investigators have used the monocytic
cell line THP-1 as a model to understand miRNA
profiles following LPS exposure. During immune
responses, numerous host proteins take part. These
may include Toll-like receptors (TLRs), nuclear fac-
tor-kappaB (NF-κB), and p38 mitogen-activated pro-
tein kinase signaling (p38 MAPK) and others. The
downstream effect of these pathways is in the libera-
tion of cytokines and other related proteins to combat
infection. miRNA species play an inherent transcrip-
tionally important function as specific alternative
genetic inhibitory transcriptional endpoints of signal-
ing cascades. The host LPS-released miRNA species
are listed in Figure 1.
Possible functions of miRNA let-7i/f and
miRNA-29b in periodontal immune responses
miRNA let-7i serves to inhibit translation of TLR 4 at
the mRNA gene level [12]. This implies miRNA let-7i
plays a pivotal role in the transcription of the
immune receptor cell signaling system. However,
this outcome may not apply to LPS from all oral
pathogens. For example, levels of some miRNAs
increase when cells are exposed to LPS from
Aggregatibacter actinomycetemcomitans (miRNA let-
7f) whereas P. gingivalis LPS-responsive TLRs (TLR
2, 4, or 7) can vary [12], and hence the LPS-respon-
sive miRNA species differ (miRNA-29b). When
investigating early miRNA responses of THP1-differ-
entiated macrophages challenged with LPS from A.
actinomycetemcomitans and P. gingivalis, Naqvi et al.
[10] confirmed the detection of expected miRNA–
mRNA interactions for P. gingivalis LPS-responsive
miRNA 29b and A. actinomycetemcomitans miRNA
let-7f using dual-luciferase assays. These experiments
discovered miRNA-29b was targeted by mRNAs
encoding interleukin (IL)-6Rα and interferon
Figure 1. A molar tooth, invariably the target of periodontitis, shows one half with healthy peridontium (left) and the other with
breached gingiva (right). Neutrophils are shown to represent their surveillance during health. Eventually, Porphyromonas
gingivalis gains attachment and enters the cell to reach the subgingival niche. Here, it is able to survive, release lipopolysac-
charide and outer membrane vesicles, and initiate periodontitis with its companion species (not shown). During disease
initiation and its progression, several miRNA species are released that maintain a molecular communication with the host
genes and self to promote its own survival and cause progressive damage to host tissues.
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gamma inducible protein 30 (IFI30) genes. Let-7f
appeared to target mRNAs encoding suppressor of
cytokine signaling 4 (SOCS4) and thrombospondin-1
(TSP-1) [10]. SOCS4 and TSP-1 are host genes that
play a role in mediating inflammation. The results by
Naqvi et al. [10] provide evidence for the expected
interplay between miRNA involvements in endotoxin
mediated innate responses for the above genes.
Effects of miRNA-128 on inflammatory
response in periodontitis
Na et al. [13] hypothesized that miRNA-128 probably
participates in the inflammatory response induced by
P. gingivalis in periodontitis. To this end, they con-
ducted experiments in which they exposed THP-1
and the oral squamous carcinoma CA9-22 cell lines
to P. gingivalis [13]. They subsequently reported
increased levels of miR-128 in the THP-1 and the
CA9-22 cells [13]. Furthermore, by treating THP-1
cells with the miR-128 mimic, the expression levels of
tumor necrosis factor-alpha (TNF-α) cytokine
decreased significantly [13]. This result identified
miRNAs with regulatory roles for TNF-α cytokine
secretion. Downregulating TNF-α by miRNA-based
therapy is of interest for treating diseases such as
osteoarthritis because this cytokine plays a critical
role in the pathogenesis of this debilitating disease
[14]. Na et al. [13] also suggested that miR-128 med-
iates endotoxin tolerance through modulation of the
p38 MAPK pathway. Thus, evolution has provided
mechanisms for controlled inflammatory response in
periodontitis that can compensate for the survival of
the bacterium by providing sufficient sustenance and
in turn maintain a chronic disease status by limiting
damage to periodontal tissues: a win–win situation
for the bacterium.
The p38 MAPK pathway signaling mediates
inflammatory and stress responses. This pathway is
critical in the regulation of levels of multiple pro-
inflammatory cytokines (e.g. TNF-α, IL-1, IL-6, and
IL-8), as well as for enzymes (cyclooxygenase and
inducible nitric oxide synthase) involved during
inflammation-mediated stress [15–17]. These
enzymes maintain a balance in the host’s intrinsic
and extrinsic oxidative stress. Given that periodontal
disease has a polymicrobial dysbiotic etiology, it is
not likely to be free from oxidative stress. Prolonged
episodes of oxidative stress produce an excessive
accumulation of reactive oxygen species, capable of
inducing deleterious cellular and biomolecular
damage to the host [18,19]. There is a paucity of
information concerning the identity of miRNA pro-
files during acute phase reactive oxygen species gen-
eration in periodontal disease. As miRNAs bring
about transcriptional endpoints of already switched-
on signaling cascades (oxidative stress/miRNA
regulation of nitric oxide synthase), their (miRNA)
existence should be expected. p38 MAPK also regu-
lates expression of matrix metalloproteinases [15,20],
which are associated with destruction and remodeling
of periodontal tissue. The increased levels of miRNA-
128 may support a regulatory function during survi-
val of P. gingivalis in the inflamed periodontium by
muting the host’s inflammatory response that would
otherwise be very harmful to the host tissues and to
some extent also for the bacterium.
Possible role for miRNA-132 in periodontitis
Park et al. [21] exposed THP-1-derived macrophages
to P. gingivalis in order to study the expression of
inflammatory miRNAs attempting to discover poten-
tial regulatory networks controlling innate immunity,
also extending beyond TLR gene regulation. They
found that P. gingivalis caused increased levels of
miRNA-132 through primed TLR2/4 and NF-κB sig-
naling, while a decreased level of miRNA-132
strongly suppressed TNF-α secretion. In this way,
Park et al. [21] discovered expression of two tran-
scription factor families (nuclear factor E2-related
factor 2 [NFE2L2], and nuclear factor activated T
cells [NFAT5]) that decreased in response to P. gin-
givalis infection. This result clearly suggests that P.
gingivalis possesses the ability to regulate expression
of inducible genes associated with immune responses
aiming to eliminate this bacterium, as both the
NFE2L2 and NFAT5 gene mRNAs are targets of
miRNA-132. Transfection of THP-1 cells with the
antagonist miRNA-132 restored levels of gene expres-
sion. These results support the conclusion that
miRNA-132 has a role in the pathogenesis of period-
ontitis induced by P. gingivalis [21].
Possible functions for miRNA-146 and miRNA-
155 in periodontitis
Increased expression of miRNA-146a and miRNA-
146a-5p from human gingival fibroblasts (HGFs) sti-
mulated with P. gingivalis LPS was reported [22].
This report described elevated expression of both
miRNA-146a and miRNA-146a-5p contributing to
increased secretion of IL-1β, IL-6, and TNF-α [22].
These are classical host-mediated responses due to
NF-κB-induced gene expression elicited by LPS. The
involvement of miRNA-146 suggests that miRNA
functions as an alternative signal to stimulate expres-
sion of genes associated with initiation of inflamma-
tion following P. gingivalis infection. Further
evidence of miRNA functions during inflammation
is derived from the finding that levels of IL-1 receptor
associated kinase 1 (IRAK1) were increased while
TNF receptor-associated factor 6 (TRAF6) levels
remained unchanged. One explanation could be that
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miRNA-146a and miRNA-146b-5p are directly
bound to 3´-UTR of IRAK1 mRNA, thereby halting
expression of TRAF6 [22]. Alternatively, miRNA-
146a and miRNA-146a-5p may act as negative regu-
lators of the immune response by inhibiting expres-
sion of IRAK1 during periodontal microbial-initiated
inflammation [22].
The miRNA-146-mediated IRAK1 response may
also inhibit the inflammatory response in macro-
phages against LPS. Li et al. [23] reported that levels
of miRNA-146a-5p were significantly elevated in
macrophages 24 h after stimulation with a high dose
of P. gingivalis LPS or an equivalent immunogen. The
pro-inflammatory P. gingivalis LPS may participate in
triggering dysregulation of the cassette transporters
ABCA1 and ABCAG1 during periodontitis. These
genes are also involved in the cholesterol transport
system [24,25], suggesting possible adverse inflamma-
tory effects in individuals suffering from dyslipide-
mia, for example individuals prone to atherosclerosis,
stroke, and Alzheimer’s disease due to the shared
apolipoprotein E, allelic variant 4 susceptibility gene
(APOE4) inheritance. As a positive, macrophages
transfected with miRNA-146a-5p mimics diminished
the dysregulation of ABCA1/G1 induced by P. gingi-
valis LPS through downregulation of IRAK1. This
demonstrates a potential therapeutic potential of can-
didate miRNA for dyslipidemic subjects. Li et al. [23]
suggested that in macrophages, miRNA-146a can
operate as an inflammatory brake on LPS stimulation
by decreasing the levels of two adapter proteins
(IRAK1 and TRAF6) in an NF-κB-dependent manner
[26], implying a strong therapeutic potential for
miRNA-based therapies.
According to Krebshull and Papapanou [1],
miRNA-146a is critical for enhancing the sensitivity
of both TLR-like receptor and miRNA-155 for TLR
in general. Also, altered levels of miRNA-146a affect
expression levels of other miRNAs, implying inter-
miRNA dependency for their regulation. Therefore,
diverse biological effects of, for example, miRNA-155
may be due to changes in levels of other miRNAs,
which are also regulated by miRNA-155, albeit
directly or indirectly [1]. For example, miRNA-155
has a role in the regulation of adaptive immunity in
periodontal disease [27], acting as a key modulator of
the T-cell response [28].
In vitro studies performed to investigate if the P.
gingivalis LPS affects levels of miRNA-146a in THP-1-
and THP-1-derived macrophages entailed decreasing or
increasing levels of miRNA-146a through transfection
with a specific antagonist or precursor, respectively [29].
The results indicated only minor effects on cytokine
production in macrophages that had been stimulated
with P. gingivalis LPS while IRAK1 and TRAF6
remained unchanged [21,29]. In contrast, Nahid et al.
[30] studying periodontitis as a polyinfection in the
ApoE–/– mouse model, found P. gingivalis LPS stimu-
lated THP-1 that were transfected with miRNA-146a
antagonist prior to stimulation led to about a 90%
decrease in the level of miRNA-146a, followed by an
increase in TNF-α response to TLR ligands. Since these
investigations tried correlating miRNA-146a changes
with decreased levels of IRAK1 and TRAF6, this has
given rise to discrepancies. While these discrepancies
could be resolved by accounting for differences in
experimental conditions, an alternative explanation is a
paucity of information regarding unknown mRNAs also
being targeted by miRNA-146a. Thus, any significance
of data from the above studies will become available
once the role of miRNA-146a in cells stimulated with
TLR ligands is established. Others have proposed [29] a
broader function for a single miRNA (e.g. miRNA-146)
because it can target several mRNAs [31].
Jiang et al. [32] reported that P. gingivalis LPS
(10 µg/mL) increased the expression of TLR2, TLR4,
and miRNA-146a in human periodontal ligament
cells (HPDLCs). At 1 µg/mL LPS, P. gingivalis
induced TLR2, miRNA-146a, and NF-κB p65 nuclear
activity and enhanced cytokine secretion but without
affecting TLR4. However, upregulation of miRNA-
146a was inhibitory to both anti-TLR2/4 monoclonal
antibodies (mAb) [32]. Rather surprisingly, after
blocking with the aforementioned mAbs, miRNA-
146a, TLR2, TLR4, NF-κB p65 nuclear activity, and
pro-inflammatory cytokines increased. These results
demonstrate subtleties in the overlapping function of
mAbs and suggest patient-tailored therapies may be
useful with dual-acting immunoglobulins. Further
research is required to understand the mechanisms
by which these mAbs exert their synergistic effect.
Experiments using HPDLCs stimulated with P. gingi-
valis LPS exposed to a miRNA-146a mimic showed
that the levels of miRNA-146a, TLR2, TLR4, NF-κB
p65 nuclear activity, and proinflammatory cytokine
parameters decreased significantly. This led to the
conclusion that miRNA-146a functions as a negative
feedback regulator by downregulating proinflamma-
tory cytokine secretion and blocking TLR signaling in
HPDLCs after stimulation with P. gingivalis LPS.
Possible role for miRNA-203 in P. gingivalis
pathogenesis
It is understood that miRNA-203 levels increase post
exposure of human gingival epithelial cells (GECs) to
live, invasive P. gingivalis. This has led to the notion
that activity of the cytokine signaling pathway regula-
tion is a miRNA-203-mediated event [33]. To this
end, GECs infected with P. gingivalis revealed an
increased level of miRNA-203, whereas levels of puta-
tive mRNA targets of miRNA-203, that is, suppressor
of cytokine signaling 3 (SOCS3) and SOCS6,
decreased (0.2 and 0.5 relative to controls) [33].
4 I. OLSEN ET AL.
SOCS3 regulates cytokine signals, which modulate
receptor activation of NF-κB ligand (RANKL)-
mediated osteoclastogenesis [34], and SOCS6 has an
important role modulating mitochondrial dynamics
and subsequent apoptotic events [35]. The results
indicate a role for miRNA-203 in the pathogenesis
of P. gingivalis by contributing to regulation of host-
cell immune responses in a manner promoting bac-
terial persistence.
P. gingivalis–dependent increase in the level
of miRNA-584 inhibits anti-inflammatory
effects
miRNA-584 targets the mRNA encoding the lactofer-
rin receptor (LfR). This was determined by exposing
the immortalized human GEC line OBA-9 to P. gingi-
valis. The results demonstrated a threefold increase in
miRNA-584 and suppression of the LfR at both the
mRNA and protein level [36]. The transfection of
OBA-9 cells with a miRNA antagonist for miRNA-
584 recovered P. gingivalis–dependent suppression of
LfR supporting the aforementioned observation. A
similar result was observed with P. gingivalis–stimu-
lated OBA-9 cells for the human lactoferrin (hLf),
which markedly downregulated the synthesis of IL-8.
This suggested that the P. gingivalis–dependent
increase in the level of miRNA-584 observed in
OBA-9 cells diminished the anti-inflammatory
response by decreasing the level of LfR. This is another
plausible transcriptional therapeutic target for mitigat-
ing inflammation.
Miscellaneous miRNAS act as regulators in P.
gingivalis LPS-induced periodontitis
Du et al. [37] examined miRNA profiles in periodontal
ligament cells (PDCLs) treated with P. gingivalis LPS.
Using miRNA microarrays, they found 50 different
miRNA species that were differentially expressed, of
which 22 exhibited increased levels and 28 exhibited
decreased levels of expression. Levels of expression of
seven randomly selected miRNAs from each popula-
tion (miRNA-21-5p, −498, and −548-5p – increased
expression) and (miRNA-495-3p, −539-5p, −34-3p,
and −7a-2-3p – decreased expression) were confirmed
using quantitative reverse transcription polymerase
chain reaction. Target analysis of these miRNAs using
the miRWalk database suggested significant associa-
tions to cellular functions related to LPS-induced per-
iodontitis. These included the TLR signaling pathway,
the cAMP-signaling pathway, the transforming growth
factor-beta signaling pathway, the MAPK signaling
pathway, and other related pathways. These results
support the notion that several miRNA species may
selectively target a single mRNA and vice versa. The
mechanism by which this genetic stimulation is
switched off during LPS-induced periodontitis remains
to be defined.
Outer membrane vesicles from P. gingivalis
containing miRNA
Bacteria communicate between themselves and with
other bacteria via signaling molecules, including LPS,
proteins, and nucleic acids found in the membrane or
lumen of outer membrane vesicles (OMVs) [38]. A
typical example is OMVs from P. gingivalis [39].
Recently, a novel class of miRNAs was characterized
in P. gingivalis, A. actinomycetemcomitans, and
Treponema denticola OMVs. This indicates that
some bacteria harbor miRNA-like molecules that
are resilient to degradation by RNAses found in the
host’s body fluids (e.g. serum and saliva). These
miRNAs are suggested to function as bacterial signal-
ing molecules that can be transferred both to other
bacteria and into host cells via OMVs, facilitating the
modulation of host immune responses [40].
Concluding remarks
The relationship between P. gingivalis and miRNAs at
present is vague. The fact that most of the reports
reviewed here originated from in vitro studies is a
reflection of this new and developing field of
research. Many of the studies discussed are from
cultured cell lines exposed to LPS. Data from LPS
experiments do not necessarily translate to the data
with live bacteria, although both approaches have
merits. However, it is clear that miRNA profiles of
healthy and diseased periodontal tissues are signifi-
cantly different [9,10]. The miRNA approach may
therefore prove to be fruitful in future studies of
periodontal disease, especially in relation to the key-
stone pathogen P. gingivalis.
Current data suggest a role for miRNA in the viru-
lence of P. gingivalis, particularly contributing to mod-
ulation of host-cell immune responses in a manner
promoting bacterial survival, and progressively redu-
cing the host’s protective function. It is rather surpris-
ing that some of the aforementioned miRNAs are also
associated with P. gingivalis itself [40] while others
(miRNA-128, miRNA-146, miRNA-203, and miRNA-
584) are host derived. It is noteworthy that the bacter-
ium-associated miRNAs are likely to influence the
innate immune response against P. gingivalis, whereas
LPS from this bacterium may affect the levels of the
host’s miRNA–mRNA interactions. These miRNA-
dependent effects may supplement other forms of
deception exerted by P. gingivalis serving to subvert
innate and adaptive immune responses. It is most
important to remember that the oral microbiome con-
sists of hundreds of microbial species, each expressing
various pro-inflammatory factors likely to be involved
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in the development of periodontitis. Therefore, the
outcome in resolving disease in the context of
miRNAs based biomarkers and therapy should envi-
sage contributions from polymicrobial infections.
It is recognized that P. gingivalis requires some
inflammatory response to acquire iron and proteins
for survival and growth. Thus, low-grade ‘tick-over’
inflammation is favorable for this bacterium and to
some degree for the host. However, the miRNAs
associated with chronic inflammatory diseases should
be targets for therapeutic interventions and, where
possible, also serve as diagnostic biomarkers.
Further research will contribute to a better under-
standing of the functions and the mode of miRNAs
working in the pathogenesis of periodontitis to deter-
mine whether and how miRNAs can be harnessed for
the diagnosis and therapy of periodontitis.
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